# FDA Inspection 1231345 - Vitalant - February 15, 2024

Source: https://www.keypedia.com/records/fda_inspections/vitalant/c3e7d3ea-9f26-4a4f-a020-bb9aa5f52081
Source feed: FDA_Inspections

> FDA Inspection 1231345 for Vitalant on February 15, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1231345
- Company Name: Vitalant
- Inspection Date: 2024-02-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1077612 - 2019-01-17](https://www.keypedia.com/records/fda_inspections/vitalant/55f425c5-c0e7-418e-8998-5eb7b5cc602a)
- [FDA Inspection 1003019 - 2017-03-10](https://www.keypedia.com/records/fda_inspections/vitalant/12a7384a-542e-4220-a4fe-c47d088360a6)

Company: https://www.keypedia.com/companies/vitalant/6a8ed582-5f91-4d5f-8abd-48a993a6b01f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d